Beyond scoring: a modern interpretation of disease progression in chronic liver disease. (Q51018265)

27 March 2018

title

Beyond scoring: a modern interpretation of disease progression in chronic liver disease. (English)

1 reference

27 March 2018

main subject

chronic liver disease

0 references

author name string

Matteo Rosselli

1

1 reference

27 March 2018

Jane MacNaughtan

2

1 reference

27 March 2018

Rajiv Jalan

3

1 reference

27 March 2018

Massimo Pinzani

4

1 reference

27 March 2018

language of work or name

English

0 references

publication date

5 May 2013

1 reference

27 March 2018

published in

Gut

1 reference

27 March 2018

volume

62

1 reference

27 March 2018

issue

9

1 reference

27 March 2018

page(s)

1234-1241

1 reference

27 March 2018

Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

New therapeutic paradigm for patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Acute-on-chronic liver failure: pathophysiological basis of therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Liver fibrosis: from the bench to clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Anti-fibrotic therapy: lost in translation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Fibrosis distribution in explanted cirrhotic livers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Angiogenesis in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Liver biopsies in chronic viral hepatitis: beyond grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

The relationship between liver disease stage and liver fibrosis: a tangled web

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Fibrosis in patients with chronic hepatitis C: detection and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Natural history and predictors of disease severity in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Genetic determinants in hepatic fibrosis: from experimental models to fibrogenic gene signatures in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Genetics of liver injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

MR imaging of liver fibrosis: current state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Renal failure and cirrhosis: a systematic review of mortality and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Portal hypertension and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

The clinical use of HVPG measurements in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Non invasive evaluation of portal hypertension using transient elastography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Role of spleen enlargement in cirrhosis with portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Acute-on chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Endotoxemia produces coma and brain swelling in bile duct ligated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Acute-on-chronic liver failure: the heart and systemic hemodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Toll-like receptors as targets in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Spontaneous bacterial peritonitis: recent guidelines and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Treatment of hepatic encephalopathy with metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Rifaximin treatment in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-302826

10.1136/GUTJNL-2012-302826

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018